deoxyepinephrine has been researched along with Cirrhosis, Liver in 4 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1 Thirty in-patients of both sexes suffering from ascitic liver cirrhosis were divided into three groups treated with (a) a placebo, (b) ibopamine (SB 7505, a new oral dopaminergic drug) and (c) frusemide, for 10 days." | 9.05 | Effectiveness of ibopamine in the management of ascitic liver cirrhosis--a controlled study v placebo and frusemide. ( Bauer, R; Ghirardi, P; Melloni, GF; Melloni, R; Minoja, GM; Piatto, E; Scarazzati, E, 1981) |
| "We investigated the renal and humoral effects of short-term administration of ibopamine, an orally active dopamine agonist, in patients with liver cirrhosis." | 7.68 | Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis. ( Badalamenti, S; Ghirardi, P; Graziani, G; Incerti, P; Lorenzano, E; Morganti, A; Salerno, F, 1990) |
| "1 Thirty in-patients of both sexes suffering from ascitic liver cirrhosis were divided into three groups treated with (a) a placebo, (b) ibopamine (SB 7505, a new oral dopaminergic drug) and (c) frusemide, for 10 days." | 5.05 | Effectiveness of ibopamine in the management of ascitic liver cirrhosis--a controlled study v placebo and frusemide. ( Bauer, R; Ghirardi, P; Melloni, GF; Melloni, R; Minoja, GM; Piatto, E; Scarazzati, E, 1981) |
| "We investigated the renal and humoral effects of short-term administration of ibopamine, an orally active dopamine agonist, in patients with liver cirrhosis." | 3.68 | Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis. ( Badalamenti, S; Ghirardi, P; Graziani, G; Incerti, P; Lorenzano, E; Morganti, A; Salerno, F, 1990) |
| " Furthermore, ibopamine-quinidine pharmacokinetic interaction and the effects of food on plasma kinetics were evaluated in NS." | 1.27 | Clinical pharmacokinetics of ibopamine on different diseases and conditions. ( Lodola, E; Ventresca, GP, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melloni, GF | 1 |
| Minoja, GM | 1 |
| Melloni, R | 1 |
| Piatto, E | 1 |
| Scarazzati, E | 1 |
| Bauer, R | 1 |
| Ghirardi, P | 2 |
| Salerno, F | 1 |
| Incerti, P | 1 |
| Badalamenti, S | 1 |
| Lorenzano, E | 1 |
| Graziani, G | 1 |
| Morganti, A | 1 |
| Ventresca, GP | 1 |
| Lodola, E | 1 |
| Scardaccio, V | 1 |
| Soggia, G | 1 |
| Vargiu, G | 1 |
| Poddighe, P | 1 |
| Manca, A | 1 |
| Serra, G | 1 |
| Sanna, M | 1 |
| Satta, A | 1 |
| Faedda, R | 1 |
| Bartoli, E | 1 |
2 trials available for deoxyepinephrine and Cirrhosis, Liver
| Article | Year |
|---|---|
Effectiveness of ibopamine in the management of ascitic liver cirrhosis--a controlled study v placebo and frusemide.
Topics: Adult; Aged; Clinical Trials as Topic; Deoxyepinephrine; Diuresis; Diuretics; Dopamine; Female; Furo | 1981 |
[Diuretic effects of ibopamine and its action on splanchnic hemodynamics].
Topics: Clinical Trials as Topic; Deoxyepinephrine; Diuretics; Dopamine; Double-Blind Method; Female; Humans | 1987 |
2 other studies available for deoxyepinephrine and Cirrhosis, Liver
| Article | Year |
|---|---|
Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis.
Topics: Adult; Aged; Aldosterone; Deoxyepinephrine; Diuretics; Dopamine; Dopamine Agents; Glomerular Filtrat | 1990 |
Clinical pharmacokinetics of ibopamine on different diseases and conditions.
Topics: Absorption; Administration, Oral; Adult; Aged; Aged, 80 and over; Biological Availability; Chemical | 1988 |